NIFTY 5022,350.75 +0.42%
SENSEX73,592.10 +0.38%
BANK NIFTY47,612.30 -0.15%
NIFTY IT35,210.45 +1.12%
NIFTY PHARMA17,890.60 +0.65%
NIFTY METAL8,412.20 -0.83%
NIFTY AUTO22,150.00 +0.27%
INDIA VIX14.25 -2.10%
NIFTY 5022,350.75 +0.42%
SENSEX73,592.10 +0.38%
BANK NIFTY47,612.30 -0.15%
NIFTY IT35,210.45 +1.12%
NIFTY PHARMA17,890.60 +0.65%
NIFTY METAL8,412.20 -0.83%
NIFTY AUTO22,150.00 +0.27%
INDIA VIX14.25 -2.10%

Nifty Maintains Bullish Bias Above 24,000; Experts Eye Adani Ports, Laurus Labs Amid Selective Trades

Amid positive election sentiment, the Nifty 50 maintained a bullish bias above 24,000, despite facing resistance at 24,200. Analysts recommend selective stock plays, highlighting Adani Ports and Laurus Labs for potential gains, while cautioning on CDSL.

·2 min read·ET Stocks

The Indian equity benchmark Nifty 50 [NIFTY] recently ended a trading session on a positive note, buoyed by prevailing positive sentiment surrounding the ongoing election process. Despite this upward momentum, the index encountered significant resistance levels near the 24,200 mark.

Market analysts are closely monitoring Nifty's performance, indicating a strong support level at 24,000. As long as the index maintains its position above these crucial levels, experts maintain a bullish bias on the broader market. This suggests that despite minor hurdles, the underlying sentiment for Indian equities remains robust.

In this dynamic environment, market experts are advising investors to adopt a strategy of selective trading. This approach emphasizes identifying fundamentally strong stocks with clear catalysts rather than a broad-market participation. Among the stocks garnering attention from analysts for potential upside, two names stand out:

  • Adani Ports and Special Economic Zone [ADANIPORTS]: Several analysts have issued a 'Buy' recommendation for Adani Ports, citing its strong market position and growth prospects within the logistics and infrastructure sector.
  • Laurus Labs [LAURUSLABS]: This pharmaceutical company has also received 'Buy' calls from experts, suggesting confidence in its business model and future performance in the competitive healthcare industry.

Conversely, some caution has been sounded regarding Central Depository Services (India) Ltd [CDSL]. While not a direct 'Sell' recommendation, analysts have noted signs of weakness in the stock, advising investors to exercise prudence or monitor its performance closely before making fresh commitments. This indicates a selective approach is crucial, even in a bullish market.

Investors are encouraged to conduct their own due diligence and consult financial advisors before acting on any market recommendations. The current market phase, characterized by positive sentiment but also specific resistance points, calls for an informed and strategic investment approach.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Stock market investments are subject to market risks. Please consult your financial advisor before making any investment decisions. StockTips.in is not a SEBI-registered investment advisor.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Stock market investments are subject to market risks. Please consult your financial advisor before making any investment decisions. StockTips.in is not a SEBI-registered investment advisor.